Post
Why aren’t eligible sites being utilised in clinical trials?
The perpetual problem of under-recruitment within clinical trials was inevitably discussed between key industry players throughout the 10th annual Outsourcing …
Signal: US lays out plan to seize govt-funded drug patents to lower cost
The Biden administration has announced plans to allow agencies to use march-in rights to seize patents of government-funded drugs if …
BMS’s Opdivo meets co-primary endpoint in colorectal cancer trial
Bristol Myers Squibb (BMS) has announced that the Phase III CheckMate-8HW trial investigating Opdivo (nivolumab) with Yervoy (ipilimumab) to treat …
Pfizer’s multiple myeloma treatment secures conditional approval in EU
Pfizer’s Elrexfio for treating multiple myeloma has been granted conditional market approval from the European Commission (EC), following a Phase …
Kymera’s protein degrader starts Phase II trial in atopic dermatitis
Kymera Therapeutics has dosed the first patient in the Phase II ADVANTA trial evaluating KT-474 in patients with atopic dermatitis …
Sanofi’s Phase III multiple myeloma trial meets primary goal
Sanofi has reported that the Phase III IMROZ clinical trial of its monoclonal antibody Sarclisa (isatuximab) plus standard-of-care for multiple …
Harmony Biosciences reports positive Phase II DM1 therapy data
Harmony Biosciences has reported positive topline data from its Phase II clinical trial of pitolisant to treat adults with myotonic …
Halia Therapeutics to test HT-6184 in MDS patients for first time
Halia Therapeutics is looking to start a Phase II trial of its pipeline candidate HT-6184 in myelodysplastic syndrome (MDS) early …
Merck to discontinue Phase III lung cancer trial due to futility
Merck (MSD) has announced plans to discontinue the Phase III KEYLYNK-008 clinical trial of Keytruda plus Lynparza regimen to treat …
NIH commences tuberculous meningitis drug combination regimen trial
The US National Institutes of Health (NIH) has commenced the Phase II IMAGINE-TBM clinical trial of a new drug combination …
New guide, new endpoint: Studying hypoglycaemia for diabetic drug efficacy
Over the last three decades, the antidiabetic drug development landscape has evolved how glucocentric and cardiocentric measures are used as …
Clinical Trials Arena Excellence Awards 2023: ProofPilot
ProofPilot is a New York based software company that provides clinical trial automation for drug development. The company is a …
Pfizer and Arvinas plan vepdegestrant programme expansion after data at SABCS
Pfizer and Arvinas are broadening their vepdegestrant programme to include more settings, as positive data is reported from the Phase …
New CDC data shows rebound in US life expectancy
For almost half a decade, trends showing a decline in US life expectancy have been the objects of surprise and …
Micro Medical completes enrollment for stent pivotal trial
Micro Medical has completed enrolment for a US pivotal clinical study evaluating the safety and effectiveness of its MicroStent system …